Merkel Cell Carcinoma Diagnosis: Questions to Ask

Merkel cell carcinoma is a rare, aggressive skin cancer. It usually starts as a fast-growing, painless bump. This often happens on skin that gets a lot of sun. Doctors confirm it with a skin biopsy. That means removing a small piece of tissue. A pathologist then examines it under a microscope for cancer cells.

Merkel cell carcinoma can look like several other skin conditions. So the pathologist often uses a technique called immunohistochemistry. This test uses antibodies to check for specific markers on the cells. It confirms the diagnosis, rather than relying on appearance alone.

Ask the clinician to write the complete diagnosis, including stage or risk group when those terms apply. Then ask which result established it.

Merkel cell carcinoma can grow and spread early. That is why a changing skin lump needs quick evaluation, more so than with many other skin cancers. Risk goes up with heavy sun exposure, including tanning beds. It also goes up with anything that weakens the immune system, including HIV or medicines taken after an organ transplant. It is more common in people over 50, in men, and in people with white skin. None of these factors confirm a diagnosis on their own. They simply explain why your doctor may have moved quickly to biopsy an unusual, fast-growing bump.

• What tissue finding confirms this diagnosis?
• Did immunohistochemistry testing confirm it was Merkel cell carcinoma and not a different skin cancer?
• Was the sample large enough to answer the important questions?
• Would review by a pathologist who regularly sees this rare cancer be useful?

Merkel cell carcinoma is staged from 0 through IV. In stage I the tumor is 2 centimeters or smaller. In stage IIA it is larger than 2 centimeters, and in stage IIB it has grown into nearby connective tissue, muscle, cartilage, or bone. Stage III means it has reached nearby lymph nodes. Stage IV means it has spread further. That could mean skin away from the original spot, or organs like the liver, lung, bone, or brain.

A key test at this stage is a sentinel lymph node biopsy. Doctors inject a radioactive tracer, a blue dye, or both, near the original tumor. This tracer travels to the first lymph node or nodes the cancer would reach if it spread. Doctors call these the sentinel nodes. Those nodes are removed and checked under a microscope. A clear result is reassuring. It is one piece of the picture, though, not the whole picture on its own.

Ask what the team knows about the extent of disease and what remains uncertain. Ask specifically whether a sentinel lymph node biopsy has been done or is planned, since it directly affects your stage and your treatment plan.

Ask where the pathology slides and imaging files are stored, and how to request them. Ask whether the current center can send them directly to another center. A second opinion does not mean rejecting the first team. This cancer is both rare and fast-moving. A second opinion from a center that regularly treats it can confirm the plan, or catch a detail worth discussing, without slowing down care much.

With most skin spots, waiting a few weeks to get checked rarely changes the outcome. Merkel cell carcinoma is different. Because it can grow and spread quickly, the time between noticing a new, fast-growing bump and getting it biopsied matters more than it would with a typical mole. If your diagnosis is confirmed, ask your team how soon staging tests and treatment planning need to happen, and whether any part of the workup should be scheduled urgently rather than routinely.

Before the visit ends, write down the next test, appointment, responsible person, and expected timing. Ask how results will arrive, and who will explain them if they show up in a portal first.

The most useful outcome is a short sentence: "This is what we know, this is what we are waiting for, and this is the decision that comes next."

• National Cancer Institute — Merkel Cell Carcinoma Treatment (PDQ).